EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes

Wensheng Shi, Jiaming Dong, Bowen Zhong, Xiheng Hu, Chunguang Zhao

Molecular Biotechnology · 2025-06 · 67 (6) · 2367-2381

DOI: 10.1007/s12033-024-01203-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biotechnology, online erschienen am 28.05.2024. Verfasst von Wensheng Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Skin Cancer and Psoriasis, Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Xiangya H…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Hypoxia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer is a prevalent malignancy with high mortality rates worldwide. Hypoxia is a critical factor in the development and progression of cancers. However, whether and how hypoxia-related genes (HRGs) could affect the development and the chemotherapy response of bladder cancer is still largely unexplored. This study comprehensively explored the complex molecular landscape associated with hypoxia in bladder cancer by analyzing 260 hypoxia genes based on transcriptomic and genomic data in 411 samples. Employing the 109 dysregulated hypoxia genes for consensus clustering, we delineated two distinct bladder cancer clusters characterized by disparate survival outcomes and distinct oncogenic roles. We defined a HPscore that was correlated with a variety of clinical features, including TNM stages and pathologic grades. Tumor immune landscape analysis identified three immune clusters and close interactions between hypoxia genes and the various immune cells. Utilizing a network-based method, we defined 129 HRGs exerting influence on apoptotic processes and critical signaling pathways in cancer. Further analysis of chemotherapy drug sensitivity identified potential drug–target HRGs. We developed a Risk Score model that was related to the overall survival of bladder cancer patients based on doxorubicin-target HRGs: ACTG2, MYC, PDGFRB, DHRS2, and KLRD1. This study not only enhanced our understanding of bladder cancer at the molecular level but also provided promising avenues for the development of targeted therapies, representing a significant step toward the identification of effective treatments and addressing the urgent need for advancements in bladder cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsHypoxiaHumansPrognosisGene Expression Regulation, NeoplasticFemaleMaleTranscriptomeGene Expression ProfilingBiomarkers, TumorAntineoplastic AgentsGenomicsDoxorubicinMultiomics

Stichwörter der Autor:innen

Bladder cancerChemotherapyDoxorubicinHypoxia-related genes (HRGs)PrognosisTumor immune microenvironment (TIME)

Substanzen

Biomarkers, TumorAntineoplastic AgentsDoxorubicin

Autor:innen und Institutionen

  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, 410008, Hunan, China.
  • Furong Laboratory, Changsha, 410008, Hunan, China.
  • Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Department of Radiation, Cangzhou Central Hospital, Hebei, 061000, China.
  • Department of Critical Care Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. 562122649@qq.com.

Förderung

  • The Natural Science Foundation of Hunan Province of China

Zitieren

APA

Shi, W., Dong, J., Zhong, B., Hu, X., & Zhao, C. (2025). Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes. Molecular Biotechnology, 67(6), 2367-2381. https://doi.org/10.1007/s12033-024-01203-9

Vancouver

Shi W, Dong J, Zhong B, Hu X, Zhao C. Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes. Molecular Biotechnology. 2025;67(6):2367-2381. doi:10.1007/s12033-024-01203-9

BibTeX
@article{Shi2025,
  author = {Shi, Wensheng and Dong, Jiaming and Zhong, Bowen and Hu, Xiheng and Zhao, Chunguang},
  title = {Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes},
  journal = {Molecular Biotechnology},
  year = {2025},
  volume = {67},
  number = {6},
  pages = {2367--2381},
  doi = {10.1007/s12033-024-01203-9}
}
Kostenlos starten →